Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Elevance Health, Inc.ANTM · Entity 2934 | EVP & General Counsel | November 03, 2020 | November 04, 2020 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Elevance Health, Inc.
Report date November 03, 2020 · Filed November 04, 2020
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 17,910 |
Ending reported balance
After 2020-11-03 transaction · row 5
5 source rows · reconciled sequenceRow 1 · 2020-11-03 · Sale · Disposed 4,780 · Balance 20,412 F1: This transaction was executed in multiple trades at prices ranging from $291.58 to $292.54. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Row 2 · 2020-11-03 · Sale · Disposed 2 · Balance 20,410 F2: This transaction was executed in multiple trades at prices ranging from $292.61 to $292.66. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Row 3 · 2020-11-03 · Sale · Disposed 2,500 · Balance 17,910 Row 4 · 2020-11-03 · Exercise / conversion · Acquired 1,893 · Balance 19,803 Row 5 · 2020-11-03 · Sale · Disposed 1,893 · Balance 17,910 |
| Employee Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $232.04 · Expires 2028-03-01 | Direct | 1,893 |
Reported balance
After 2020-11-03 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2020-11-03 · Exercise / conversion · Disposed 1,893 · Balance 1,893 F3: The option represents a right to purchase a total of 11,354 shares, and is exercisable in six semi-annual installments, with four installments of 1,892 shares each and two installments of 1,893 shares each, beginning on September 1, 2018, which is the six-month anniversary of the option grant date. |
Filing footnotes · ownership attribution and instrument terms
F1: This transaction was executed in multiple trades at prices ranging from $291.58 to $292.54. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F2: This transaction was executed in multiple trades at prices ranging from $292.61 to $292.66. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F3: The option represents a right to purchase a total of 11,354 shares, and is exercisable in six semi-annual installments, with four installments of 1,892 shares each and two installments of 1,893 shares each, beginning on September 1, 2018, which is the six-month anniversary of the option grant date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 03, 2020 Filed Nov 4, 2020 21:42 UTC | Elevance Health, Inc. ANTM · Entity 2934 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 1,893 | $0.00 Strike: $232.04 | $0.00 |
DisclosureSEC source: 0001156039-20-000091 · wf-form4_160452615626230.xml · derivative · entry 6 ZIELINSKI THOMAS C · CIK 0001234091 · EVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,893 Underlying: Common Stock · 1,893 shares Expires 2028-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option represents a right to purchase a total of 11,354 shares, and is exercisable in six semi-annual installments, with four installments of 1,892 shares each and two installments of 1,893 shares each, beginning on September 1, 2018, which is the six-month anniversary of the option grant date. Read SEC document |
| November 03, 2020 Filed Nov 4, 2020 21:42 UTC | Elevance Health, Inc. ANTM · Entity 2934 | SaleCommon Stock | 1,893 | $292.32 | $553,361.76 |
DisclosureSEC source: 0001156039-20-000091 · wf-form4_160452615626230.xml · nonDerivative · entry 5 ZIELINSKI THOMAS C · CIK 0001234091 · EVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,910 Read SEC document |
| November 03, 2020 Filed Nov 4, 2020 21:42 UTC | Elevance Health, Inc. ANTM · Entity 2934 | Exercise / conversionCommon Stock | 1,893 | $232.04 | $439,251.72 |
DisclosureSEC source: 0001156039-20-000091 · wf-form4_160452615626230.xml · nonDerivative · entry 4 ZIELINSKI THOMAS C · CIK 0001234091 · EVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,803 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 03, 2020 Filed Nov 4, 2020 21:42 UTC | Elevance Health, Inc. ANTM · Entity 2934 | SaleCommon Stock | 2,500 | $292.35 | $730,875.00 |
DisclosureSEC source: 0001156039-20-000091 · wf-form4_160452615626230.xml · nonDerivative · entry 3 ZIELINSKI THOMAS C · CIK 0001234091 · EVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,910 Read SEC document |
| November 03, 2020 Filed Nov 4, 2020 21:42 UTC | Elevance Health, Inc. ANTM · Entity 2934 | SaleCommon Stock | 2 | $292.64 | $585.28 |
DisclosureSEC source: 0001156039-20-000091 · wf-form4_160452615626230.xml · nonDerivative · entry 2 ZIELINSKI THOMAS C · CIK 0001234091 · EVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,410 F2 · price: This transaction was executed in multiple trades at prices ranging from $292.61 to $292.66. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| November 03, 2020 Filed Nov 4, 2020 21:42 UTC | Elevance Health, Inc. ANTM · Entity 2934 | SaleCommon Stock | 4,780 | $292.07 | $1,396,094.60 |
DisclosureSEC source: 0001156039-20-000091 · wf-form4_160452615626230.xml · nonDerivative · entry 1 ZIELINSKI THOMAS C · CIK 0001234091 · EVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,412 F1 · price: This transaction was executed in multiple trades at prices ranging from $291.58 to $292.54. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| June 08, 2020 Filed Jun 10, 2020 20:34 UTC | Elevance Health, Inc. ANTM · Entity 2934 | SaleCommon Stock | 6,358 | $297.70 | $1,892,776.60 |
DisclosureSEC source: 0001156039-20-000060 · wf-form4_159182123559313.xml · nonDerivative · entry 1 ZIELINSKI THOMAS C · CIK 0001234091 · EVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,192 Read SEC document |
| April 30, 2020 Filed May 4, 2020 20:39 UTC | Elevance Health, Inc. ANTM · Entity 2934 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 2,553 | $0.00 Strike: $166.97 | $0.00 |
DisclosureSEC source: 0001156039-20-000030 · wf-form4_158862472321215.xml · derivative · entry 6 ZIELINSKI THOMAS C · CIK 0001234091 · EVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,553 shares Expires 2027-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The option represents a right to purchase a total of 15,314 shares, and is exercisable in six semi-annual installments, with four installments of 2,552 shares each and two installments of 2,553 shares each, beginning on September 1, 2017, which is the six-month anniversary of the option grant date. Read SEC document |
| April 30, 2020 Filed May 4, 2020 20:39 UTC | Elevance Health, Inc. ANTM · Entity 2934 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 1,892 | $0.00 Strike: $232.04 | $0.00 |
DisclosureSEC source: 0001156039-20-000030 · wf-form4_158862472321215.xml · derivative · entry 5 ZIELINSKI THOMAS C · CIK 0001234091 · EVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,786 Underlying: Common Stock · 1,892 shares Expires 2028-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option represents a right to purchase a total of 11,354 shares, and is exercisable in six semi-annual installments, with four installments of 1,892 shares each and two installments of 1,893 shares each, beginning on September 1, 2018, which is the six-month anniversary of the option grant date. Read SEC document |
| April 30, 2020 Filed May 4, 2020 20:39 UTC | Elevance Health, Inc. ANTM · Entity 2934 | SaleCommon Stock | 14,861 | $278.17 | $4,133,884.37 |
DisclosureSEC source: 0001156039-20-000030 · wf-form4_158862472321215.xml · nonDerivative · entry 4 ZIELINSKI THOMAS C · CIK 0001234091 · EVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,550 F2 · price: This transaction was executed in multiple trades at prices ranging from $278.00 to $278.78. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| April 30, 2020 Filed May 4, 2020 20:39 UTC | Elevance Health, Inc. ANTM · Entity 2934 | SaleCommon Stock | 4,445 | $278.90 | $1,239,710.50 |
DisclosureSEC source: 0001156039-20-000030 · wf-form4_158862472321215.xml · nonDerivative · entry 3 ZIELINSKI THOMAS C · CIK 0001234091 · EVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,411 F1 · price: This transaction was executed in multiple trades at prices ranging from $278.44 to $279.28. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| April 30, 2020 Filed May 4, 2020 20:39 UTC | Elevance Health, Inc. ANTM · Entity 2934 | Exercise / conversionCommon Stock | 2,553 | $166.97 | $426,274.41 |
DisclosureSEC source: 0001156039-20-000030 · wf-form4_158862472321215.xml · nonDerivative · entry 2 ZIELINSKI THOMAS C · CIK 0001234091 · EVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,856 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 30, 2020 Filed May 4, 2020 20:39 UTC | Elevance Health, Inc. ANTM · Entity 2934 | Exercise / conversionCommon Stock | 1,892 | $232.04 | $439,019.68 |
DisclosureSEC source: 0001156039-20-000030 · wf-form4_158862472321215.xml · nonDerivative · entry 1 ZIELINSKI THOMAS C · CIK 0001234091 · EVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,303 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 02, 2020 Filed Mar 4, 2020 21:41 UTC | Elevance Health, Inc. ANTM · Entity 2934 | GrantEmployee Stock Option (Right to Buy) · Derivative | 12,253 | $0.00 Strike: $271.27 | $0.00 |
DisclosureSEC source: 0001127602-20-009436 · form4.xml · derivative · entry 4 ZIELINSKI THOMAS C · CIK 0001234091 · EVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,253 Underlying: Common Stock · 12,253 shares Expires 2030-03-02 F4 · derivative.exercise_date: The option represents a right to purchase a total of 12,253 shares, and is exercisable in three annual installments, with two installments of 4,084 shares each and one installment of 4,085 shares, beginning on 3/2/2021, which is the one-year anniversary of the option grant date. Read SEC document |
| March 02, 2020 Filed Mar 4, 2020 21:41 UTC | Elevance Health, Inc. ANTM · Entity 2934 | GrantCommon Stock | 28,784 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-009436 · form4.xml · nonDerivative · entry 3 ZIELINSKI THOMAS C · CIK 0001234091 · EVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,411 F3 · shares: Represents performance based restricted share units. Restrictions lapse on 3/2/2020. Read SEC document |
| March 02, 2020 Filed Mar 4, 2020 21:41 UTC | Elevance Health, Inc. ANTM · Entity 2934 | GrantCommon Stock | 2,304 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-009436 · form4.xml · nonDerivative · entry 2 ZIELINSKI THOMAS C · CIK 0001234091 · EVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,627 F2 · shares: Represents restricted share units. Restrictions lapse as follows: 768 shares each on 3/2/2021, 3/2/2022 and 3/2/2023. Read SEC document |
| March 02, 2020 Filed Mar 4, 2020 21:41 UTC | Elevance Health, Inc. ANTM · Entity 2934 | Tax withholdingCommon Stock | 13,769 | $271.27 | $3,735,116.63 |
DisclosureSEC source: 0001127602-20-009436 · form4.xml · nonDerivative · entry 1 ZIELINSKI THOMAS C · CIK 0001234091 · EVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,323 F1 · shares: PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK. Read SEC document |
| December 04, 2019 Filed Dec 6, 2019 21:15 UTC | Elevance Health, Inc. ANTM · Entity 2934 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 2,553 | $0.00 Strike: $166.97 | $0.00 |
DisclosureSEC source: 0001127602-19-034460 · form4.xml · derivative · entry 7 ZIELINSKI THOMAS C · CIK 0001234091 · EVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,553 Underlying: Common Stock · 2,553 shares Expires 2027-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The option represents a right to purchase a total of 15,314 shares, and is exercisable in six semi-annual installments, with four installments of 2,552 shares each and two installments of 2,553 shares each, beginning on September 1, 2017, which is the six-month anniversary of the option grant date. Read SEC document |
| December 04, 2019 Filed Dec 6, 2019 21:15 UTC | Elevance Health, Inc. ANTM · Entity 2934 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 1,892 | $0.00 Strike: $232.04 | $0.00 |
DisclosureSEC source: 0001127602-19-034460 · form4.xml · derivative · entry 6 ZIELINSKI THOMAS C · CIK 0001234091 · EVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,678 Underlying: Common Stock · 1,892 shares Expires 2028-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option represents a right to purchase a total of 11,354 shares, and is exercisable in six semi-annual installments, with four installments of 1,892 shares each and two installments of 1,893 shares each, beginning on September 1, 2018, which is the six-month anniversary of the option grant date. Read SEC document |
| December 04, 2019 Filed Dec 6, 2019 21:15 UTC | Elevance Health, Inc. ANTM · Entity 2934 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 3,064 | $0.00 Strike: $108.35 | $0.00 |
DisclosureSEC source: 0001127602-19-034460 · form4.xml · derivative · entry 5 ZIELINSKI THOMAS C · CIK 0001234091 · EVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,064 shares Expires 2021-06-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option represents a right to purchase a total of 21,191 shares, and is exercisable in six semi-annual installments with one installment of 3,531 shares and five installments of 3,532 shares each beginning on December 2, 2014, which is the six-month anniversary of the date on which the option was granted. Read SEC document |
| December 04, 2019 Filed Dec 6, 2019 21:15 UTC | Elevance Health, Inc. ANTM · Entity 2934 | SaleCommon Stock | 10,600 | $288.33 | $3,056,298.00 |
DisclosureSEC source: 0001127602-19-034460 · form4.xml · nonDerivative · entry 4 ZIELINSKI THOMAS C · CIK 0001234091 · EVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,092 F1 · price: This transaction was executed in multiple trades at prices ranging from $288.00 to $288.85. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| December 04, 2019 Filed Dec 6, 2019 21:15 UTC | Elevance Health, Inc. ANTM · Entity 2934 | Exercise / conversionCommon Stock | 2,553 | $166.97 | $426,274.41 |
DisclosureSEC source: 0001127602-19-034460 · form4.xml · nonDerivative · entry 3 ZIELINSKI THOMAS C · CIK 0001234091 · EVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,692 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 04, 2019 Filed Dec 6, 2019 21:15 UTC | Elevance Health, Inc. ANTM · Entity 2934 | Exercise / conversionCommon Stock | 1,892 | $232.04 | $439,019.68 |
DisclosureSEC source: 0001127602-19-034460 · form4.xml · nonDerivative · entry 2 ZIELINSKI THOMAS C · CIK 0001234091 · EVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,139 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 04, 2019 Filed Dec 6, 2019 21:15 UTC | Elevance Health, Inc. ANTM · Entity 2934 | Exercise / conversionCommon Stock | 3,064 | $108.35 | $331,984.40 |
DisclosureSEC source: 0001127602-19-034460 · form4.xml · nonDerivative · entry 1 ZIELINSKI THOMAS C · CIK 0001234091 · EVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,247 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 11, 2019 Filed Jun 13, 2019 20:22 UTC | Elevance Health, Inc. ANTM · Entity 2934 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 3,382 | $0.00 Strike: $131.80 | $0.00 |
DisclosureSEC source: 0001127602-19-021556 · form4.xml · derivative · entry 9 ZIELINSKI THOMAS C · CIK 0001234091 · EVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,382 shares Expires 2026-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: The option represents a right to purchase a total of 20,289 shares, and is exercisable in six semi-annual installments, with three installments of 3,381 shares each and three installments of 3,382 shares each, beginning on September 1, 2016, which is the six-month anniversary of the option grant date. Read SEC document |
| June 11, 2019 Filed Jun 13, 2019 20:22 UTC | Elevance Health, Inc. ANTM · Entity 2934 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 2,552 | $0.00 Strike: $166.97 | $0.00 |
DisclosureSEC source: 0001127602-19-021556 · form4.xml · derivative · entry 8 ZIELINSKI THOMAS C · CIK 0001234091 · EVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,106 Underlying: Common Stock · 2,552 shares Expires 2027-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The option represents a right to purchase a total of 15,314 shares, and is exercisable in six semi-annual installments, with four installments of 2,552 shares each and two installments of 2,553 shares each, beginning on September 1, 2017, which is the six-month anniversary of the option grant date. Read SEC document |
| June 11, 2019 Filed Jun 13, 2019 20:22 UTC | Elevance Health, Inc. ANTM · Entity 2934 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 1,892 | $0.00 Strike: $232.04 | $0.00 |
DisclosureSEC source: 0001127602-19-021556 · form4.xml · derivative · entry 7 ZIELINSKI THOMAS C · CIK 0001234091 · EVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,570 Underlying: Common Stock · 1,892 shares Expires 2028-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option represents a right to purchase a total of 11,354 shares, and is exercisable in six semi-annual installments, with four installments of 1,892 shares each and two installments of 1,893 shares each, beginning on September 1, 2018, which is the six-month anniversary of the option grant date. Read SEC document |
| June 11, 2019 Filed Jun 13, 2019 20:22 UTC | Elevance Health, Inc. ANTM · Entity 2934 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 1,000 | $0.00 Strike: $108.35 | $0.00 |
DisclosureSEC source: 0001127602-19-021556 · form4.xml · derivative · entry 6 ZIELINSKI THOMAS C · CIK 0001234091 · EVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,064 Underlying: Common Stock · 1,000 shares Expires 2021-06-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option represents a right to purchase a total of 21,191 shares, and is exercisable in six semi-annual installments with one installment of 3,531 shares and five installments of 3,532 shares each beginning on December 2, 2014, which is the six-month anniversary of the date on which the option was granted. Read SEC document |
| June 11, 2019 Filed Jun 13, 2019 20:22 UTC | Elevance Health, Inc. ANTM · Entity 2934 | SaleCommon Stock | 8,826 | $283.92 | $2,505,877.92 |
DisclosureSEC source: 0001127602-19-021556 · form4.xml · nonDerivative · entry 5 ZIELINSKI THOMAS C · CIK 0001234091 · EVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,183 F1 · price: This transaction was executed in multiple trades at prices ranging from $283.92 to $284.01. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| June 11, 2019 Filed Jun 13, 2019 20:22 UTC | Elevance Health, Inc. ANTM · Entity 2934 | Exercise / conversionCommon Stock | 3,382 | $131.80 | $445,747.60 |
DisclosureSEC source: 0001127602-19-021556 · form4.xml · nonDerivative · entry 4 ZIELINSKI THOMAS C · CIK 0001234091 · EVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,009 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 11, 2019 Filed Jun 13, 2019 20:22 UTC | Elevance Health, Inc. ANTM · Entity 2934 | Exercise / conversionCommon Stock | 2,552 | $166.97 | $426,107.44 |
DisclosureSEC source: 0001127602-19-021556 · form4.xml · nonDerivative · entry 3 ZIELINSKI THOMAS C · CIK 0001234091 · EVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,627 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 11, 2019 Filed Jun 13, 2019 20:22 UTC | Elevance Health, Inc. ANTM · Entity 2934 | Exercise / conversionCommon Stock | 1,892 | $232.04 | $439,019.68 |
DisclosureSEC source: 0001127602-19-021556 · form4.xml · nonDerivative · entry 2 ZIELINSKI THOMAS C · CIK 0001234091 · EVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,075 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 11, 2019 Filed Jun 13, 2019 20:22 UTC | Elevance Health, Inc. ANTM · Entity 2934 | Exercise / conversionCommon Stock | 1,000 | $108.35 | $108,350.00 |
DisclosureSEC source: 0001127602-19-021556 · form4.xml · nonDerivative · entry 1 ZIELINSKI THOMAS C · CIK 0001234091 · EVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,183 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 01, 2019 Filed Mar 5, 2019 21:17 UTC | Elevance Health, Inc. ANTM · Entity 2934 | GrantEmployee Stock Option (Right to Buy) · Derivative | 9,378 | $0.00 Strike: $307.68 | $0.00 |
DisclosureSEC source: 0001127602-19-009925 · form4.xml · derivative · entry 4 ZIELINSKI THOMAS C · CIK 0001234091 · EVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,378 Underlying: Common Stock · 9,378 shares Expires 2029-03-01 F4 · derivative.exercise_date: The option represents a right to purchase a total of 9,378 shares, and is exercisable in three annual installments of 3,126 shares each, beginning on 3/1/2020, which is the one-year anniversary of the option grant date. Read SEC document |
| March 01, 2019 Filed Mar 5, 2019 21:17 UTC | Elevance Health, Inc. ANTM · Entity 2934 | GrantCommon Stock | 2,032 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-009925 · form4.xml · nonDerivative · entry 3 ZIELINSKI THOMAS C · CIK 0001234091 · EVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,183 F3 · shares: Represents restricted share units. Restrictions lapse as follows: 677 shares each on 3/1/2020 and 3/1/2021, and 678 on 3/1/2022. Read SEC document |
| March 01, 2019 Filed Mar 5, 2019 21:17 UTC | Elevance Health, Inc. ANTM · Entity 2934 | GrantCommon Stock | 10,138 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-009925 · form4.xml · nonDerivative · entry 2 ZIELINSKI THOMAS C · CIK 0001234091 · EVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,151 F2 · shares: Represents performance based restricted share units. Restrictions lapse on 3/1/19. Read SEC document |
| March 01, 2019 Filed Mar 5, 2019 21:17 UTC | Elevance Health, Inc. ANTM · Entity 2934 | Tax withholdingCommon Stock | 6,071 | $307.68 | $1,867,925.28 |
DisclosureSEC source: 0001127602-19-009925 · form4.xml · nonDerivative · entry 1 ZIELINSKI THOMAS C · CIK 0001234091 · EVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,013 F1 · shares: PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK. Read SEC document |
| November 07, 2018 Filed Nov 9, 2018 21:08 UTC | Elevance Health, Inc. ANTM · Entity 2934 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 1,892 | $0.00 Strike: $232.04 | $0.00 |
DisclosureSEC source: 0001127602-18-032631 · form4.xml · derivative · entry 7 ZIELINSKI THOMAS C · CIK 0001234091 · EVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,462 Underlying: Common Stock · 1,892 shares Expires 2028-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The option represents a right to purchase a total of 11,354 shares, and is exercisable in six semi-annual installments, with four installments of 1,892 shares each and two installments of 1,893 shares each, beginning on September 1, 2018, which is the six-month anniversary of the option grant date. Read SEC document |
| November 07, 2018 Filed Nov 9, 2018 21:08 UTC | Elevance Health, Inc. ANTM · Entity 2934 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 2,552 | $0.00 Strike: $166.97 | $0.00 |
DisclosureSEC source: 0001127602-18-032631 · form4.xml · derivative · entry 6 ZIELINSKI THOMAS C · CIK 0001234091 · EVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,658 Underlying: Common Stock · 2,552 shares Expires 2027-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option represents a right to purchase a total of 15,314 shares, and is exercisable in six semi-annual installments, with four installments of 2,552 shares each and two installments of 2,553 shares each, beginning on September 1, 2017, which is the six-month anniversary of the option grant date. Read SEC document |
| November 07, 2018 Filed Nov 9, 2018 21:08 UTC | Elevance Health, Inc. ANTM · Entity 2934 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 3,382 | $0.00 Strike: $131.80 | $0.00 |
DisclosureSEC source: 0001127602-18-032631 · form4.xml · derivative · entry 5 ZIELINSKI THOMAS C · CIK 0001234091 · EVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,382 Underlying: Common Stock · 3,382 shares Expires 2026-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option represents a right to purchase a total of 20,289 shares, and is exercisable in six semi-annual installments, with three installments of 3,381 shares each and three installments of 3,382 shares each, beginning on September 1, 2016, which is the six-month anniversary of the option grant date. Read SEC document |
| November 07, 2018 Filed Nov 9, 2018 21:08 UTC | Elevance Health, Inc. ANTM · Entity 2934 | SaleCommon Stock | 7,826 | $289.71 | $2,267,270.46 |
DisclosureSEC source: 0001127602-18-032631 · form4.xml · nonDerivative · entry 4 ZIELINSKI THOMAS C · CIK 0001234091 · EVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,084 F1 · price: This transaction was executed in multiple trades at prices ranging from $289.69 to $289.84. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| November 07, 2018 Filed Nov 9, 2018 21:08 UTC | Elevance Health, Inc. ANTM · Entity 2934 | Exercise / conversionCommon Stock | 1,892 | $232.04 | $439,019.68 |
DisclosureSEC source: 0001127602-18-032631 · form4.xml · nonDerivative · entry 3 ZIELINSKI THOMAS C · CIK 0001234091 · EVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,910 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 07, 2018 Filed Nov 9, 2018 21:08 UTC | Elevance Health, Inc. ANTM · Entity 2934 | Exercise / conversionCommon Stock | 2,552 | $166.97 | $426,107.44 |
DisclosureSEC source: 0001127602-18-032631 · form4.xml · nonDerivative · entry 2 ZIELINSKI THOMAS C · CIK 0001234091 · EVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,018 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 07, 2018 Filed Nov 9, 2018 21:08 UTC | Elevance Health, Inc. ANTM · Entity 2934 | Exercise / conversionCommon Stock | 3,382 | $131.80 | $445,747.60 |
DisclosureSEC source: 0001127602-18-032631 · form4.xml · nonDerivative · entry 1 ZIELINSKI THOMAS C · CIK 0001234091 · EVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,466 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 13, 2018 Filed Mar 15, 2018 20:30 UTC | Elevance Health, Inc. ANTM · Entity 2934 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 5,104 | $0.00 Strike: $166.97 | $0.00 |
DisclosureSEC source: 0001127602-18-011705 · form4.xml · derivative · entry 10 ZIELINSKI THOMAS C · CIK 0001234091 · EVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,210 Underlying: Common Stock · 5,104 shares Expires 2027-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: The option represents a right to purchase a total of 15,314 shares, and is exercisable in six semi-annual installments, with four installments of 2,552 shares each and two installments of 2,553 shares each, beginning on September 1, 2017, which is the six-month anniversary of the option grant date. Read SEC document |
| March 13, 2018 Filed Mar 15, 2018 20:30 UTC | Elevance Health, Inc. ANTM · Entity 2934 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 6,763 | $0.00 Strike: $131.80 | $0.00 |
DisclosureSEC source: 0001127602-18-011705 · form4.xml · derivative · entry 9 ZIELINSKI THOMAS C · CIK 0001234091 · EVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,764 Underlying: Common Stock · 6,763 shares Expires 2026-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: The option represents a right to purchase a total of 20,289 shares, and is exercisable in six semi-annual installments, with three installments of 3,381 shares each and three installments of 3,382 shares each, beginning on September 1, 2016, which is the six-month anniversary of the option grant date. Read SEC document |
| March 13, 2018 Filed Mar 15, 2018 20:30 UTC | Elevance Health, Inc. ANTM · Entity 2934 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 5,588 | $0.00 Strike: $146.93 | $0.00 |
DisclosureSEC source: 0001127602-18-011705 · form4.xml · derivative · entry 8 ZIELINSKI THOMAS C · CIK 0001234091 · EVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,588 shares Expires 2025-03-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The option, representing a right to purchase a total of 16,762 shares and is exercisable in six semi annual installments with two installments of 2,793 shares each and four installments of 2,794 shares each beginning on September 2, 2015, which is the six-month anniversary of the date on which the option was granted. Read SEC document |
| March 13, 2018 Filed Mar 15, 2018 20:30 UTC | Elevance Health, Inc. ANTM · Entity 2934 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 3,000 | $0.00 Strike: $108.35 | $0.00 |
DisclosureSEC source: 0001127602-18-011705 · form4.xml · derivative · entry 7 ZIELINSKI THOMAS C · CIK 0001234091 · EVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,064 Underlying: Common Stock · 3,000 shares Expires 2021-06-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option represents a right to purchase a total of 21,191 shares, and is exercisable in six semi-annual installments with one installment of 3,531 shares and five installments of 3,532 shares each beginning on December 2, 2014, which is the six-month anniversary of the date on which the option was granted. Read SEC document |
| March 13, 2018 Filed Mar 15, 2018 20:30 UTC | Elevance Health, Inc. ANTM · Entity 2934 | SaleCommon Stock | 6,200 | $229.80 | $1,424,760.00 |
DisclosureSEC source: 0001127602-18-011705 · form4.xml · nonDerivative · entry 6 ZIELINSKI THOMAS C · CIK 0001234091 · EVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,084 F2 · price: This transaction was executed in multiple trades at prices ranging from $229.50 to $230.22. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| March 13, 2018 Filed Mar 15, 2018 20:30 UTC | Elevance Health, Inc. ANTM · Entity 2934 | SaleCommon Stock | 14,255 | $228.98 | $3,264,109.90 |
DisclosureSEC source: 0001127602-18-011705 · form4.xml · nonDerivative · entry 5 ZIELINSKI THOMAS C · CIK 0001234091 · EVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,284 F1 · price: This transaction was executed in multiple trades at prices ranging from $228.49 to $229.47. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.